Having worked over 20 years in the pharmaceutical industry, most recently as Head of Intellectual Property for Sanofi- Synthélabo in France, he handles mainly chemical and pharmaceutical subject matter. Gordon has an in-depth knowledge of IP topics specifically related to the pharmaceutical industry, including in particular supplementary protection certificates (SPCs), regulatory data exclusivity, product life cycle management, pharmaceutical trade marks, parallel imports and arrangements, often taking a key part in structuring the deal and drafting the agreements. Gordon is well known for his numerous lectures at both professional and commercial conferences, covering a wide range of IP topics related to the pharmaceutical industry.